Recent Updates
Recently added Catalysts
KMTS Positive Sentiment Score: 85/100

Kestra Medical Technologies to Showcase Innovation in Sudden Cardiac Arrest Protection and Recovery at Heart Rhythm 2025

Key Takeaway: Kestra Medical Technologies will showcase its ASSURE® system at Heart Rhythm 2025, aiming to enhance protection and recovery for patients at risk of sudden cardiac arrest. This event marks the company's first major showcase following its IPO, and it will feature new clinical data related to the ASSURE system's impact. Additionally, Kestra will emphasize its commitment to innovation and equity in cardiovascular care by sponsoring the Women in EP Luncheon for the fourth consecutive year.

Market Sentiment Analysis

POSITIVE FACTORS

  • Kestra will showcase the innovative ASSURE® system at a major industry event.
  • The device aims to redefine protection and support for patients at risk of sudden cardiac arrest.
  • The company is experiencing increased momentum following a successful IPO.
  • Kestra's commitment to equity in cardiovascular care is highlighted by sponsoring the Women in EP Luncheon.

Full Press Release Details

KIRKLAND, Wash., April 23, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS) (“Kestra”), a wearable medical device and digital healthcare company, announced today it will exhibit at Heart Rhythm 2025, the annual meeting of the Heart Rhythm Society (HRS), taking place April 24-27 at the San Diego Convention Center. This marks Kestra’s first major industry showcase following its successful IPO earlier this year.
Kestra will debut an immersive in-booth experience designed to bring the ASSURE® system to life—demonstrating how this innovative technology is redefining protection for patients at risk of sudden cardiac arrest. By combining lifesaving defibrillation therapy with intuitive, intelligent, and connected diagnostic and patient support capabilities, the ASSURE system is a key part of a broader vision for a holistic cardiac care ecosystem that supports patients and providers across the recovery journey.
“Our presence at Heart Rhythm 2025 comes at a pivotal time for Kestra,” said Brian Webster, President and Chief Executive Officer of Kestra. “Following our IPO, we’re moving forward with increasing momentum—and this year’s HRS meeting is an opportunity to demonstrate how the ASSURE system goes beyond protection to offer a smarter, more connected recovery experience for both patients and care teams.”
In addition to exhibiting, Kestra will also present new real-world clinical data highlighting the impact of the ASSURE system. Kestra is also proud to sponsor the Women in EP Luncheon for the fourth consecutive year—underscoring its ongoing commitment to leadership, innovation, and equity in cardiovascular care.
Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. For more information, please visit www.kestramedical.com.

Contact Data

This press release doesn't contain an email address to contact.

Frequently Asked Questions

What is Kestra Medical Technologies known for?

Kestra Medical Technologies specializes in wearable medical devices and digital healthcare.

When is Heart Rhythm 2025 taking place?

Heart Rhythm 2025 will be held from April 24-27 at the San Diego Convention Center.

What is the ASSURE® system?

The ASSURE system offers defibrillation therapy and advanced diagnostic capabilities for cardiac care.

What event does Kestra sponsor at Heart Rhythm 2025?

Kestra sponsors the Women in EP Luncheon, promoting equity in cardiovascular care.

What was significant about Kestra's participation in Heart Rhythm 2025?

This is Kestra’s first major showcase after its IPO, highlighting its momentum and innovation.

Last updated: Apr 23, 2025